Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products

Regulations
Feb.23
Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products
The Oregon Senate voted 26–1 to pass Senate Bill 1571, a measure redefining tobacco products to include nicotine pouches and restricting their sale to individuals under 21.

Key Points

 

 Senate Bill 1571 passed the Oregon Senate on a 26–1 vote.

 

 The bill redefines tobacco products to include nicotine pouches.

 

 Sales to individuals under 21 would be explicitly prohibited under state law.

 

 The measure removes a proposed ban on online tobacco sales.

 

 The bill now advances to the Oregon House.

 


 

2Firsts, February 22, 2026 

 

According to Oregon Capital Chronicle, The Oregon Senate has passed Senate Bill 1571, legislation aimed at closing a regulatory gap concerning nicotine pouch products.

 

The bill, approved in a 26–1 vote on Friday, redefines tobacco products under Oregon law to include nicotine pouches. Under current state law, nicotine pouches are not classified as tobacco products, allowing retailers without tobacco licenses to sell them and subjecting them to fewer restrictions than cigarettes and vaping devices.

 

Sen. Lisa Reynolds, D-Portland, the bill’s sponsor, said the legislation addresses what she described as a loophole enabling youth access. Federal law already prohibits the sale of nicotine products to individuals under 21, and the bill would align Oregon statute with that standard.

 

Supporters cited rising youth usage of nicotine pouch products. A University of Southern California study found that twice as many teenagers reported using nicotine pouches in 2024 compared to 2023.

 

More than 70 individuals and organizations submitted written testimony on the bill, including representatives from local public health departments and youth advocacy groups, with most expressing support.

 

An earlier version of the bill included a provision prohibiting online sales of tobacco products and requiring face-to-face transactions. That section was removed in the amended version passed by the Senate.

 

The amended bill previously passed unanimously out of the Senate Judiciary Committee and now heads to the Oregon House for further consideration.

 

(Cover Image source: oregonlegislature.gov)

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025
Nicotine Becomes Second-Largest Revenue Source for Couche-Tard in Fiscal 2025
Alimentation Couche-Tard reported that nicotine products accounted for 9% of total revenue in fiscal 2025, making it the company’s second-largest revenue source after fuel, according to its latest Business Strategy Update.
Market
Feb.19
Smoore, Distributors Move to Toss Cannabis Vape Price-Fixing Suit
Smoore, Distributors Move to Toss Cannabis Vape Price-Fixing Suit
Several vape manufacturers and distributors, including Shenzhen Smoore Technology Co. Ltd., Smoore International Holdings, 3Win Corp., Jupiter Research LLC, Canna Brand Solutions, and Greenlane Holdings Inc., have filed motions seeking dismissal of consumer claims in consolidated antitrust litigation in the U.S. District Court for the Northern District of California.
Events
Feb.24
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
Michigan Proposes 57% Vape Tax in $800M Revenue Plan
Michigan Proposes 57% Vape Tax in $800M Revenue Plan
Michigan Governor Gretchen Whitmer’s FY2027 executive budget proposes a new 57% wholesale tax on vaping products and oral nicotine items as part of a broader $800 million revenue package aimed at stabilizing Medicaid funding.
Regulations
Feb.23
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
New Nicotine Products Added to Tax List in Delaware Budget Proposal
New Nicotine Products Added to Tax List in Delaware Budget Proposal
Delaware Governor Matt Meyer’s proposed FY2027 budget would significantly raise cigarette and nicotine product taxes to help close a $500 million budget gap and generate new revenue. The cigarette tax would rise from $2.10 to $3.60 per pack, with increases on moist snuff, e-liquids and other tobacco products. Supporters say the move is justified, while small businesses warn of potential sales losses.
Feb.17